Scrip Asia 100 - Attracting brains and the big bucks
This article was originally published in Scrip
You may also be interested in...
Funds will be used to expand European sales of the CE-marked Lenire device, scale-up manufacturing and progress US regulatory and reimbursement plans.
The company is the second big medtech to announce a major investment in R&D in the country in 2020.
IDE trial of SoniVie’s catheter device will be the first for a denervation treatment for PAH.